SAA2 and COVID-19: In this regard, recent studies reported an impaired interferon signaling response in tracheal aspirates of patients with severe COVID-19, which may serve as a mechanism underlying reduced SAA2 stimulation in the lower respiratory tract of COVID-19 patients with ARDS [45,46].